Las Vegas, NV -- (SBWIRE) -- 10/04/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Brandywine Realty Trust (NYSE:BDN), Exelixis, Inc. (NASDAQ:EXEL), Smith & Wesson Holding Corp (NASDAQ:SWHC)
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) managed to keep its fall at -2.75% on above-normal volume of 2.09M shares. The stock settled at $2.83 after floating in a range of $2.75 to $2.92. Its latest price has reached market capitalization of $1.45 billion. Its 52-week range has been $1.55 to $3.18. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets.
Has LXRX Found The Bottom and Ready To Move Up? Find Out Here
Brandywine Realty Trust (NYSE:BDN) traded down on a volume of 2.03 million, higher than its standard daily volume. Shares have dropped-1.91% to $12.83. Over the last twelve months, the stock has gained 5.25% and faced a worst price of $10.95. Brandywine Realty Trust is a self-administered and self-managed REIT, which provides leasing, property management, development, redevelopment, acquisition and other tenant-related services for a portfolio of office, mixed-use and industrial properties.
For How Long BDN’s Gloss will Attract Investors? Find out via this report
Exelixis, Inc. (NASDAQ:EXEL) settled -2.38% lower at $5.75 on remained same volume of 2.03M shares during the last trading day. The stock has its 12-month high at $5.96 and 52-week low price was $4.29. It traded in a range of $5.62 to $5.90 during the last trading day. Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer.
Will EXEL Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Smith & Wesson Holding Corp (NASDAQ:SWHC) was down on low volume, trading at a volume of 1.99 M versus its average daily volume of 2.36 million shares. At $10.81, the stock has attained market capitalization of 677.27 million. Smith & Wesson Holding Corporation (Smith & Wesson) is a manufacturer of firearms. The Company manufactures a range of handguns, modern sporting rifles, hunting rifles, black powder firearms, handcuffs, and firearm-related products and accessories for sale to a range of customers, including gun enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement and security agencies and officers, and military agencies in the United States and globally.
Why Should Investors Buy SWHC After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)